NOLA-B Nolato AB (publ)

5.177USD52.60 SEK · STO-0.57%Mkt Cap: 1.39B USDP/E: 21.12

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Sol…

Institutional holders11 on file

Key Statistics

Company
Market Cap1.39B USD
Enterprise Value1.57B USD
Revenue (TTM)943.25M USD
Gross Profit170.28M USD
Net Income (TTM)76.48M USD
Revenue/Share3.50 USD
Last Price5.177 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees5.8K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0015962477
Valuation
P/E (Trailing)21.12
P/E (Forward)17.95
PEG3.79
EV/EBITDA10.86
EV/Revenue1.67
P/S1.48
P/B2.37
EPS (TTM)0.25 USD
EPS (Forward)0.29 USD
52W Range
4.41043% of range6.181
52W High6.181 USD
52W Low4.410 USD
Profitability
Gross Margin18.28%
Oper. Margin10.00%
EBITDA Margin15.34%
Profit Margin8.21%
ROE14.05%
ROA8.37%
ROIC11.95%
ROCE13.79%
Growth
Revenue Growth6.70%
Earnings Growth-20.00%
Cash Flow & Leverage
Operating CF104.53M USD
CapEx (TTM)77.66M USD
FCF Margin0.40%
FCF Yield0.27%
Net Debt176.39M USD
Net Debt/EBITDA1.22
Net Debt/FCF47.31
Balance Sheet
Debt/Equity0.26
Current Ratio1.38
Quick Ratio0.78
Book Value/Sh2.18 USD
Cash/Share0.21 USD
Dividends
Fwd Div Rate0.17 USD
Trail. Div Rate0.17 USD
Div. Yield3.21%
5Y Avg Yield2.89%
Payout Ratio68.00%
Ex-Div DateMay 7, 2026
Pay Date—
Splits
Last Split10:1
Split DateMay 12, 2021
Analyst Consensus
Rating—
Target (Mean)6.447 USD
Upside (mean)+24.5%
Target Range6.201 USD – 6.693 USD
6.201+24.5% to mean6.693
# Analysts2
Ownership
Shares Out.241.79M
Float149.53M
Insiders20.47%
Institutions58.96%
Technical
SMA 505.333 (-2.9%)
SMA 2005.020 (+3.1%)
Beta0.74
S&P 52W Chg12.00%
Avg Vol (30d)238.44K
Avg Vol (10d)271.70K
Technical Indicators
RSI (14)44.7
MACD-0.5496
MACD Signal-0.6174
MACD Hist.+0.0678
BB Upper5.554 USD
BB Middle5.220 USD
BB Lower4.885 USD
BB Width12.82%
ATR (14)0.1306 USD
Vol Ratio (20d)0.61x

About Nolato (STO: NOLA-B)

›

Nolato (STO: NOLA-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 5,755 employees.

The shares were at 52.60 SEK on 19 November 2026, down 10.5% over 52 weeks. Its 52-week range is 44.80 SEK to 62.80 SEK: the price is 16.2% below the high and 17.4% above the low.

At a market capitalisation of 14.17B SEK, it trades at 21.1 times trailing earnings and 18.0 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 18% for NOLA-B. It pays a dividend yielding 3.21% (it pays out 68% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

Nolato reports return on equity of 14.0%, an operating margin of 10.0% and revenue up 6.7% year over year.

Its debt exceeds its cash by 1.79B SEK, a debt-to-equity ratio of 0.26. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 2 analysts cover the stock; their mean price target of 65.50 SEK is 24.5% above the current price. The next earnings report is expected on 8 February 2027.